Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

0.5569
BATS BZX Real-Time Price
As of 12:05pm ET
 +0.0069 / +1.25%
Today’s Change
0.41
Today|||52-Week Range
2.24
-61.59%
Year-to-Date
Biotech's Dumbest CEO Moves in 2016
10:12am / MotleyFool.com - Paid Partner Content
3 Biotech Investing Tips That Could Earn You Thousands
Nov 28 / MotleyFool.com - Paid Partner Content
MannKind (MNKD): Strong Industry, Solid Earnings Estimate Revisions
Dec 01 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.55
Today’s open0.56
Day’s range0.52 - 0.57
Volume95,944
Average volume (3 months)3,802,691
Market cap$263.1M
Dividend yield--
Data as of 12:05pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+112.45%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...+0.28+3.93%
CARACara Therapeutics In...+0.10+1.05%
PPHMPPeregrine Pharmaceut...-0.14-0.70%
ESPREsperion Therapeutic...+0.54+4.88%
Data as of 12:07pm ET, 12/05/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs